Routine Deworming in Adults is Not Recommended
For adults living in non-endemic areas or without specific risk factors, routine deworming is not indicated. The evidence-based approach to deworming in adults is targeted rather than routine, focusing on specific populations with documented exposure or infection risk.
When Adults Should Be Dewormed
Targeted Treatment Approach
Adults should be dewormed only in specific circumstances 1:
- Confirmed infection: When stool microscopy, PCR, or serology confirms helminth infection
- Returning travelers/migrants: Those with eosinophilia or symptoms after travel to endemic areas
- High-risk exposures: Recent travel with freshwater exposure (schistosomiasis risk) or barefoot walking in endemic areas (hookworm risk)
- Pre-immunosuppression screening: Before starting corticosteroids or other immunosuppressive therapy, particularly screening for Strongyloides to prevent hyperinfection syndrome 2
Empirical Treatment (Single Dose Only)
For asymptomatic adults with eosinophilia and travel history to endemic areas, consider one-time empirical treatment with albendazole 400 mg plus ivermectin 200 μg/kg as a single dose 1. This is not "routine" deworming but rather diagnostic-therapeutic intervention.
Critical caveat: Exclude Loa loa infection before giving ivermectin in anyone who has traveled to endemic regions (Central/West Africa), as treatment can cause severe adverse reactions 1.
Why Routine Deworming is Not Recommended for Adults
Lack of Evidence for Mass Treatment
The available evidence demonstrates that mass deworming programs show minimal benefit even in children from endemic areas 3, 4:
- No significant impact on weight, hemoglobin, or cognitive function in community-wide programs
- Effects limited to individuals with confirmed heavy infections
- Population-level deworming does not improve mortality or nutritional outcomes 5
Adults Are Not a Priority Population
Current WHO guidelines focus deworming efforts on:
- School-age children (6-18 years)
- Preschool children in high-prevalence areas
- Pregnant women in specific circumstances
Adults are not included in routine mass drug administration programs because they typically have lower infection intensities and develop partial immunity with age 1, 6.
Specific Clinical Scenarios
For Migrants or Long-term Residents from Endemic Areas
- Screen with stool microscopy/PCR and Strongyloides serology 1
- Treat only if positive
- No routine repeated dosing without documented infection
For Travelers Returning from Endemic Areas
- Evaluate based on symptoms and eosinophilia
- If asymptomatic with normal eosinophil count: no treatment needed
- If symptomatic or eosinophilic: investigate then treat specific infections identified 1
For Healthcare Workers or Laboratory Personnel
- No routine deworming
- Treat only if occupational exposure results in documented infection
Common Pitfalls to Avoid
- Do not treat repeatedly without documented infection: Unlike some pediatric programs in endemic areas, adults should not receive scheduled repeat dosing
- Do not assume all travelers need deworming: Most travelers do not acquire helminth infections
- Do not give ivermectin without excluding loiasis: This can cause fatal encephalopathy 1
- Do not forget Strongyloides screening before immunosuppression: This is the one scenario where proactive screening/treatment is essential 2
The Bottom Line
There is no schedule for "routine" deworming in adults. Treatment should be infection-driven, based on documented exposure, symptoms, laboratory findings (especially eosinophilia), or confirmed parasitology. The concept of regular scheduled deworming every 6-12 months, as sometimes practiced in children in highly endemic areas, has no role in adult medicine outside of very specific high-transmission settings with documented ongoing exposure.